BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao LJ, Zhang YJ, Dong SQ, Li XZ, Tong XT, Chen D, Wu ZY, Zheng XH, Xue WQ, Jia WH, Zhang JB. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling. J Exp Clin Cancer Res 2021;40:109. [PMID: 33757572 DOI: 10.1186/s13046-021-01905-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fu J, Zhang J, Chen X, Liu Z, Yang X, He Z, Hao Y, Liu B, Yao D. ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target. Theranostics 2023;13:787-809. [PMID: 36632213 DOI: 10.7150/thno.78840] [Reference Citation Analysis]
2 Gao Y, Cheng X, Han M. ZEB1-activated Notch1 promotes circulating tumor cell migration and invasion in lung squamous cell carcinoma. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02993-7] [Reference Citation Analysis]
3 Saikia M, Bhattacharyya DK, Kalita JK. CBDCEM: An effective centrality based differential co-expression method for critical gene finding. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101688] [Reference Citation Analysis]
4 Liu H, Wen Q, Yan S, Zeng W, Zou Y, Liu Q, Zhang G, Zou J, Zou X. Tumor-Promoting ATAD2 and Its Preclinical Challenges. Biomolecules 2022;12:1040. [DOI: 10.3390/biom12081040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]